Figure 1.

Technical considerations in terms of number of planned vs. performed treatment sessions and bead sizes and irinotecan doses used. Flowchart representing the number of planned uni- and bilobar tents, number of patients that did not complete the treatment plan (a). Flow chart representing the resulting number of performed uni- and bilobar treatments (b). The number of planned (dark blue) and actually performed (light blue) sessions per patients for uni- and bilobar treatment schedules (c). The number of sessions performed with 100 µm and 200 µm beads loaded with ≤50 mg, ≤100 mg and >100 mg irinotecan. The colours indicate the percentage of liver involvement from dark blue (>50%), medium blue (25–50%) and light blue (<25%) (d).